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ORIGINAL ARTICLE
Are APOE ε genotype and TOMM40 poly-T repeat length
associations with cognitive ageing mediated by brain white
matter tract integrity?
DM Lyall1,2,3,4, SE Harris1,4, ME Bastin1,2,5, S Muñoz Maniega1,2,5, C Murray1,3, MW Lutz6, AM Saunders6, AD Roses6,7,
M del C Valdés Hernández1,2,5, NA Royle1,2,5, JM Starr1,8, DJ Porteous1,4, JM Wardlaw1,2,5 and IJ Deary1,3
Genetic polymorphisms in the APOE ε and TOMM40 ‘523’ poly-T repeat gene loci have been associated with significantly increased
risk of Alzheimer’s disease. This study investigated the independent effects of these polymorphisms on human cognitive ageing,
and the extent to which nominally significant associations with cognitive ageing were mediated by previously reported genetic
associations with brain white matter tract integrity in this sample. Most participants in the Lothian Birth Cohort 1936 completed a
reasoning-type intelligence test at age 11 years, and detailed cognitive/physical assessments and structural diffusion tensor brain
magnetic resonance imaging at a mean age of 72.70 years (s.d. = 0.74). Participants were genotyped for APOE ε2/ε3/ε4 status and
TOMM40 523 poly-T repeat length. Data were available from 758–814 subjects for cognitive analysis, and 522–543 for mediation
analysis with brain imaging data. APOE genotype was significantly associated with performance on several different tests of
cognitive ability, including general factors of intelligence, information processing speed and memory (raw P-values allo0.05),
independently of childhood IQ and vascular disease history. Formal tests of mediation showed that several significant APOE-
cognitive ageing associations—particularly those related to tests of information processing speed—were partially mediated by
white matter tract integrity. TOMM40 523 genotype was not associated with cognitive ageing. A range of brain phenotypes are
likely to form the anatomical basis for significant associations between APOE genotype and cognitive ageing, including white
matter tract microstructural integrity.
Translational Psychiatry (2014) 4, e449; doi:10.1038/tp.2014.89; published online 23 September 2014
INTRODUCTION
Alzheimer’s disease (AD) is a progressive neurodegenerative
disease characterized by cognitive impairment. Two genetic
risk factors for late onset Alzheimer’s disease are in the apo-
lipoprotein-e (APOE; http://www.ncbi.nlm.nih.gov/gene/348) and
translocase of outer mitochondrial membrane 40 (TOMM40) gene
poly-T repeat loci (http://www.ncbi.nlm.nih.gov/gene/10452).1,2
Previous studies have investigated associations between APOE
genotype and cognitive ability in non-demented older adults.
Wisdom et al.3 conducted a meta-analysis of 77 studies, excluding
samples with any disorders that may affect cognitive ability such
as dementia or Parkinson’s disease (final N= 40 942; weighted
estimate mean age = 63.14 years, s.d. = 13.10). For analytic
purposes, they then constructed a ‘d’ effect size metric that
weighted standardized differences between the groups in terms
of sample sizes. Significant deleterious effects of the ε4 allele were
found for cognitive domains of episodic memory, global cognitive
function, executive function and perceptual speed (all Po0.05).
There were no significant effects on verbal ability, primary
memory, attention or visuospatial functioning.
The association between APOE ε4 and cognitive ability may be
modified by other genetic variables that exert independent
effects.4 The TOMM40 523 poly-T repeat locus has recently been
significantly associated with brain-related phenotypes (for exam-
ple, cognitive decline), independent of APOE genotype.5 The
independent effects of this locus on older-age cognitive ability
have been examined in three studies. The largest of these was by
Caselli et al.6 who reported a deleterious effect of the Very-long/
Very-long genotype (vs Short/Short) on the amount of long-
itudinal change in the auditory verbal learning test (N= 639;
genotype mean ages = 57.8–60.9 years; mean duration of follow-
up = 6.1 years ± 3.1; P= 0.04 in APOE ε3/ε3 subgroup). Two other
smaller reports by Hayden et al.7 (N= 127) and Johnson et al.8
(N= 117) have also reported some specific significant effects of
TOMM40 523 genotype on cognitive ability in older adults.
One of the main aims of this paper is to investigate brain
imaging variables that might mediate previously established
genetic-cognitive associations; it is important to understand the
anatomical brain substrates of cognitive ageing. Penke et al.9
investigated the role of white matter integrity using different
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metrics obtained from diffusion tensor magnetic resonance
imaging (DT-MRI), one of which was fractional anisotropy (FA;
where lower FA reflects reduced brain white matter integrity).
They reported that a general factor of FA constructed with
principal components analysis (PCA) was significantly associated
with general factors of processing speed (gspeed; standardized
β=− 0.19) and general cognitive ability (g; standardized β= 0.13)
in the Lothian Birth Cohort 1936 (LBC1936), explaining around
10% of the variance in general cognitive ability. Specifically, lower
FA scores were associated with worse general cognitive ability,
and slower information processing speed.
A previous report by Lyall et al.10 tested for associations
between APOE/TOMM40 523 genotypes and tract-averaged FA
values in several brain white matter tracts in the 73-year-old
LBC1936 (the same sample whose data are analysed in the present
study), assessed by DT-MRI. We found significant and independent
deleterious effects of the APOE ε4 and TOMM40 523 ‘Short’ (vs
Long/Very-long) alleles on specific tracts, independent of the
covariates of age, gender, vascular disease history and childhood
intelligence. For APOE genotype, these tracts were the left ventral
cingulum and the left inferior longitudinal fasciculus, and for
TOMM40 523, the left uncinate fasciculus, left rostral cingulum, left
ventral cingulum and GFA. The statistically significant association
with GFA—which reflects shared variance among the examined
tracts—may indicate a general effect of TOMM40 523 on white
matter tract integrity in the brain. It is unclear why tract-specific
measures show significant deleterious effects of genetic variation
at the APOE/TOMM40 gene loci, compared with other white matter
tracts.10 These specific tracts may be particularly sensitive to injury
or pathology.11 (Note however that group differences in white
matter FA may be due to differences in, for example, axon
diameter, packing density or membrane permeability, and in this
sense lower FA may not necessarily reflect lower microstructural
integrity per se.12 ) In that report (Lyall et al.10), we did not assess
the effects of APOE/TOMM40 523 genotypes on cognitive ability,
and we are aware of no studies that formally test the extent to
which deleterious effects of APOE ε4 on cognitive ageing are
mediated by brain white matter tract integrity (although see Ryan
et al.13).
The present study therefore aims to: (1) assess the effects of
APOE/TOMM40 523 genotypes on cognitive abilities in older
people, at first unadjusted and then adjusted for age 11
intelligence (that is, reflecting cognitive ageing); and (2) determine
the extent to which any such significant associations are mediated
by previously reported associations between these gene loci and
white matter tract integrity (FA), assessed with DT-MRI in this same
sample.10
MATERIALS AND METHODS
Sample
The LBC1936 is a longitudinal ageing sample of generally healthy,
community-dwelling older adults.14,15 Briefly, most of the LBC1936 sample
completed the Moray House Test (no.12) of verbal reasoning as part of the
Scottish Mental Survey 1947 at a mean age of 11 years, and were recruited
for detailed cognitive, medical and demographic assessments at the
Wellcome Trust Clinical Research Facility (WTCRF, Edinburgh; http://www.
wtcrf.ed.ac.uk) around the ages of ~ 70 (Wave 1) and ~ 73 years (Wave 2). It
is the Wave 2 data that are examined here. Participants also received
detailed brain MRI around the same time (mean interval = 65.1 days16).
Diagnoses of clinical conditions were elicited via interview. Clinical vascular
conditions asked about included high blood pressure, diabetes, stroke,
high cholesterol and any vascular pathology. All subjects gave written,
informed consent.
Genotyping
Participants were genotyped for APOE ε on the basis of DNA isolated from
whole blood taken from the Wave 1 (age 70) assessment, and genotyped
by TaqMan assay (Applied Biosystems, Carlsbad, CA, USA) at the WTCRF
genetics core.15 TOMM40 523 was genotyped by the laboratory of Dr Ornit
Chiba-Falek (Duke University, Durham, NC, USA) using a method described
previously.17
Cognitive assessment
Moray house test no.12. This was completed in June 1947 at a mean age
of 11 years. This assessment has a 45-min time limit, has a maximum score
of 76 and includes questions with a range of numerical, visuospatial and
(primarily) verbal reasoning items.15 Scores were adjusted for age in days
at the time of assessment, and standardized to an IQ score with a mean of
100 and s.d. of 15 for the whole LBC1936 sample.
Assessment of cognitive domains. The tests completed at a mean age of
73 years in Wave 2 are described by Deary et al.14,15 In brief, the cognitive
domains assessed were as follows. Working memory was assessed with
digit span backwards and letter-number sequencing (both from the WAIS-
IIIUK battery18). Processing speed was assessed using: digit symbol coding
and symbol search tests from the WAIS-IIIUK; simple reaction time (RT), and
four-choice RT via a self-contained device;19 and a visual discrimination
task called Inspection Time, which assesses speed of basic visual
processing and where higher total scores reflect better performance.15
Verbal declarative memory was assessed with the verbal paired associates I
and II, and logical memory I and II tests (both from the WMS-IIIUK battery20).
Specifically, we summed the respective I/II test scores to create verbal
paired associates total scores, and logical memory total scores for each
individual. Visuospatial ability and memory were assessed with block
design and spatial span (WAIS-IIIUK and WMS-IIIUK, respectively). Abstract
reasoning was assessed using matrix reasoning from the WAIS-IIIUK.
Data reduction was applied to the cognitive test scores using three
separate PCAs, which produced the following summary cognitive variables.
First, ‘general intelligence’ (g) included the six nonverbal Wechsler subtests
of digit span backwards, matrix reasoning, letter-number sequencing,
block design, symbol search and digit symbol coding. Second, ‘processing
speed’ (gspeed) included symbol search, digit symbol coding, simple RT,
four-choice RT and Inspection time.21 Third, a ‘memory’ factor (gmemory)
was formed from logical memory, spatial span, verbal paired associates,
letter-number sequencing and digit span backwards.22 The first unrotated
principal component score in each domain accounted for 50–54% of the
respective variance, and all individual variables had high loadings on their
respective first unrotated components. Strictly speaking, PCA does not
produce latent factors, however, we use the term here because it is a
common usage.
In each PCA, the g/gspeed/gmemory scores reflect variance that is shared
between their respective lists of included cognitive tests, hence eliminat-
ing task-specific variance.23 However because different tasks assess specific
aspects of mental ability (for example, logical memory explicitly assesses
declarative verbal memory), it is still informative to include tests of
association between APOE/TOMM40 genotypes and these individual test-
score phenotypes.24 Further, the large battery of tests applied to the
LBC1936 is rare, and other research teams are likely to test relationships
studied here with individual tests. Therefore, to allow comparisons with
others’ work, we include the individual test results in addition to the
component scores.
Diffusion MRI and tractography
The protocol for DT-MRI processing is described in detail in the MRI
protocol paper, including imagine acquisition parameters of the DTI
sequence.16 Briefly, participants underwent whole-brain diffusion MRI
acquired using a GE Signa Horizon HDxt 1.5T clinical scanner (General
Electric, Milwaukee, WI, USA). The diffusion MRI data were preprocessed
using FSL tools (FMRIB, Oxford, UK; http://www.fmrib.ox.ac.uk). Underlying
tractography connectivity data were generated using BedpostX/Prob-
TrackX with a two-fibre model.25 Fourteen tracts were identified using
probabilistic neighbourhood tractography, an approach for automatic and
reproducible tract segmentation.26,27 These tracts were considered to be of
relevance to cognitive and brain ageing, on the basis of several lines of
evidence.16
To make sure that segmented tracts were anatomically plausible
representations of the tract-of-interest, a researcher inspected all masks,
blind to all other data and excluded tracts with aberrant or truncated
pathways. Generally, the probabilistic neighbourhood tractography
method, which had been designed specifically for use in older brains,
Association of APOE/TOMM40 genotypes with cognitive ageing
DM Lyall et al
2
Translational Psychiatry (2014), 1 – 7 © 2014 Macmillan Publishers Limited
reliably segmented the twelve tracts of interest; tracts that did not meet
quality critera (for example, truncation, aberrant route), ranged from 0.3%
for the splenium of the corpus callosum, to 16% for the left anterior
thalamic radiation (mean= 5% (ref. 16)). The protocol paper by Wardlaw
et al.16 is an open access article that details specific methodology of
probabilistic neighbourhood tractography for each tract, and displays
examples of tracts segmented for use in the LBC1936 sample. Tracts
assessed were the genu and splenium of corpus callosum, and bilateral
anterior thalamic radiations, ventral and rostral cingulum bundles, arcuate,
uncinate and inferior longitudinal fascicule; see Lyall et al.10 for a detailed
examination of associations between APOE/TOMM40 523 and average FA
scores for these tracts.
Statistical analysis
APOE/TOMM40 analysis. We first tested the effects of APOE ε4 allele
presence vs absence, that is, pooled ε2/ε4, ε3/ε4 and ε4/ε4 genotypes vs
pooled ε2/ε2, ε2/ε3 and ε3/ε3.
The variable-length poly-T repeat rs10524523 (‘523’) was split into three
categories:28 ‘Short’ (o20T residues; S), ‘Long’ (≥20; L) and ‘Very-long’
(≥30; VL) of which the S allele may or may not be protective in terms of
neurodegenerative pathology.5 In the first analytic step applied to the
whole sample (‘Step 1’), a general linear model tested for a significant
effect of the TOMM40 523 genotype (that is, S/S; S/L; L/L; L/VL; VL/VL). To
investigate the effects of TOMM40 523 repeat length independent of
biological variation in APOE genotype, analysis then focussed separately on
two different APOE ε genotype subgroups. First, participants with the ε3/ε4
genotype were analysed (‘Step 2’); the S allele may offset or interact
biologically with the ε3/ε4 ‘risk’ genotype.29 Finally, analysis focussed on
participants with the ‘neutral’ APOE genotype (ε3/ε3; ‘Step 3’), because this
eliminates variance associated with protective and risk APOE alleles.8 This
subgroup analysis means that any statistically significant effects of
TOMM40 523 genotype cannot be attributed to variation in APOE ε status.
In steps 2 and 3 (i.e., analysis of TOMM40 523 in APOE ε3/ε4 and ε3/ε3
genotype subgroups, respectively), the L and VL alleles were pooled into
an “L*” group, as is relatively common;10 participants with the S/S
genotype were compared with those carrying only one S allele (pooled S/L
and S/VL; hereinafter S/L*), and also against participants carrying no S
alleles (pooled L/L, L/VL, and VL/VL; hereinafter L*/L*).6
Covariate models. All covariate models controlled for age and gender
(‘Model 1’). Cognitive scores were then corrected for age 11 IQ, to
investigate ‘cognitive ageing’ (‘Model 2’). Significant associations were
then were re-tested controlling for the following covariates in addition to
those in Model 2; self-reported history of hypertension, stroke, type 2
diabetes, hypercholesterolaemia and all-inclusive vascular disease (‘Model
3’).30 This reduces the chance that any significant associations occur as
secondary to genetic associations with vascular pathology.
An online calculator was used to perform tests of Hardy–Weinberg
equilibrium and determine minor allele frequencies (http://www.had2know.
com/academics/hardy-weinberg-equilibrium-calculator-3-alleles.html). Data
were otherwise analysed with IBM Statistical Package for the Social
Sciences, Version 19.0 (SPSS, Chicago, IL, USA). Specifically, univariate
general linear models tested the fixed effects of separate APOE and
TOMM40 genotypes upon the outcome variables. Outliers of more than
3.30 s.d. from mean values were removed from all cognitive variables to
exclude outlying data; this did not affect any final results. To protect
against Type 1 errors, false discovery rate (FDR) was used to estimate the
number of truly significant findings in the context of testing multiple
associations.31 A Microsoft Excel program32 was used to conduct classical
one-stage FDR based on associations with cognitive abilities. P-values
o0.05 were considered to be nominally significant. All P-values are raw
unless stated as being FDR-adjusted.
Mediation analysis. Mediation analysis was used to test the indirect effect
of the predictor variable (APOE/TOMM40) on the outcome (cognitive
ageing), through the hypothesized mediator (white matter integrity).
Mediation analysis was run using the INDIRECT bootstrapping macro.33
Briefly, variable X’s effects (APOE/TOMM40) on variable Y (cognitive ageing)
can be either direct, or indirect via variable M (white matter integrity). In
Figure 1, path a represents the effect of X on M, while path b represents
the effect of M on Y, partialling out the effect of X. The direct effect of X on
Y is represented by path c. The indirect effect can then be quantified as the
combined product of paths a and b. The bias-corrected bootstrapping
point estimate coefficients that are reported here each reflect this indirect
product.33
Bootstrapping point estimate coefficients were unstandardized and
averaged over 5000 bootstrap estimates.33 The indirect point estimate
coefficients (commonly simply ‘effects’) were considered statistically
significant if the 95% confidence intervals (CIs) did not cross 0.00.33 This
method has been used previously to investigate the brain substrates of
genetic-cognitive ageing associations.34
RESULTS
Descriptive statistics
Of the 1091 LBC1936 participants originally enrolled in the study,
866 attended Waves 1 and 2. Individuals who had Mini-Mental
State Examination scores o24, a cutoff commonly used to
indicate dementia,35 did not complete the Mini-Mental State
Examination at Wave 2, or had a reported history of dementia
were excluded from analysis. Overall, this left 859 participants, of
which 811 and 823 participants had successful genotyping for
APOE and TOMM40, respectively.
APOE had allele frequencies of ε2 = 7.3%, ε3 = 76.9% and
ε4 = 15.8%, with genotype frequencies of: ε2/ε2 = 3 (0.4%), ε2/
ε3 = 95 (11.7%), ε2/ε4 = 18 (2.2%), ε3/ε3 = 472 (58.2%), ε3/ε4 = 208
(25.6%), and ε4/ε4 = 15 (1.8%) (total n= 811). TOMM40 523 had
allele frequencies of S = 41.0%, L = 15.4% and VL = 43.6%, with
genotype frequencies of S/S = 125 (15.2%), S/L = 123 (14.9%), S/
VL = 302 (36.7%), L/L = 18 (2.2%), L/VL = 95 (11.5%) and VL/VL = 160
(19.4%) (total n= 823). Exact tests confirmed that APOE and
TOMM40 were in Hardy–Weinberg equilibrium (P-values = 0.44 and
0.06, respectively).
APOE, TOMM40 and cognitive ability—not adjusted for childhood
intelligence (Model 1)
Significant deleterious/negative effects of the APOE ε4 allele (vs
absence) were found on three tasks: specifically symbol search
(P= 0.048), inspection time (P= 0.004) and spatial span (P= 0.033;
see Supplementary Table 1). For TOMM40 523, no significant
effects were found in the whole sample (‘Step 1’) or ε3/ε3
genotype subgroup (‘Step 3’). A single significant protective effect
of the S allele was found in APOE ε3/ε4 genotype subgroup only,
for letter-number sequencing (P= 0.035; ‘Step 2’; see
Supplementary Table 2). Neither APOE ε nor TOMM40 523
genotypes were associated with age 11 IQ scores themselves
(P40.05; see Supplementary Tables 1 and 2).
APOE, TOMM40 and cognitive ability—adjusted for childhood
intelligence (Models 2 and 3)
Significant deleterious effects of APOE ε4 allele presence (vs
absence) were found for nine out of a possible fifteen age
Mediator M
(white matter 
integrity)
Variable Y
(cognitive ageing)
Variable X
(genotype)
a b
c
Figure 1. An example mediation model, where variable X’s effects
(APOE/TOMM40) on variable Y (cognitive ageing) can be either direct,
or indirect via variable M (white matter integrity). Path a represents
the effect of X on M, while path b represents the effect of M on Y,
partialling out the effect of X. The direct effect of X on Y is
represented by path c (adapted from Preacher and Hayes33).
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73 ‘cognitive ageing’ variables (see Table 1). Specifically these
were g (P= 0.005), matrix reasoning (P= 0.041), gspeed(P= 0.016),
digit symbol coding (P= 0.048), symbol search (P= 0.014), inspec-
tion time (P= 0.001), gmemory (P= 0.020), logical memory Total
(P= 0.013) and spatial span (P= 0.008; ‘Step 1’). Each significant
association survived correction for vascular disease history
(Po0.05; see Supplementary Table 3).
As shown in Table 2, two significant protective associations with
S allele possession were found for TOMM40 523: in the whole
sample for spatial span (P= 0.043; ‘Step 1’), and for letter-number
sequencing in the APOE ε3/ε4 genotype subgroup only (P= 0.035;
‘Step 2’). The significant association with spatial span scores did
not remain significant when corrected for possession of the APOE
ε4 allele (P40.05). The significant association with letter-number
sequencing attenuated to (marginal) nonsignificance when
corrected for vascular disease history (P= 0.050, rounded down).
Because of this, associations between TOMM40 523 and cognitive
ageing were not examined further.
Correction for multiple testing with FDR
When the above tests of associations were corrected for multiple
testing with FDR, all significant associations attenuated to
nonsignificance (all FDR-adjusted P-values 40.05). Further
exploratory analyses were conducted on the basis that they could
provide directions for future studies.
Mediation: intercorrelations between white matter tract integrity
and cognitive ageing
Analyses next examined the mediation of genetic-cognitive
ageing associations via white matter tract integrity metrics. We
examined correlations between white matter tract variables,
which showed significant raw deleterious association with APOE
ε4 possession as reported by Lyall et al.10—namely left inferior
longitudinal fasciculus FA and right ventral cingulum FA—and
cognitive ageing variables, which were significantly associated
with APOE ε4 in the present report after correction for vascular
disease history, that is, those at Po0.05 in Table 1 which survived
this correction (see Supplementary Table 3 for the exact data).
As can be seen in Table 3, several semi-partial correlations
between white matter tract FA metrics and cognitive scores were
statistically significant, controlling for age, gender and age 11 IQ,
where both the cognitive and imaging variables were also
associated with APOE ε4 (detailed below).
Mediation: APOE/TOMM40→white matter tract
integrity→ cognitive ageing
Brain imaging and cognitive variables that showed nominally
significant raw associations with APOE ε4, and that were
themselves significantly correlated, were examined further for
mediation. Analyses tested exploratory mediation on the basis of
the above correlations, with the bootstrapping technique.33
Bootstrapping statistics indicated that left inferior longitudinal
fasciculus FA significantly mediated the association between APOE
and g (indirect effect =− 0.02, 95% CIs =− 0.05 to − 0.00), gspeed
(indirect effect =− 0.03, 95% CIs =− 0.07 to − 0.01), digit symbol
Table 1. APOE ε and cognitive ability at age 73 years, adjusted for age
11 IQ
Cognitive test ε4 allele presence (vs absence)
(d.f.) F statistics P Partial η2
General factor: intelligence (g) (1, 746)=8.04 0.005 0.011
Digit span backwards (1, 755)= 0.53 0.468 0.001
Matrix reasoning (1, 754)=4.19 0.041 0.006
Block design (1, 753)= 3.70 0.055 0.005
Letter-number sequencing (1, 754)= 0.70 0.403 0.001
General factor: processing
speed (gspeed)
(1, 716)=5.80 0.016 0.008
Digit symbol coding (1, 753)=3.92 0.048 0.005
Symbol search (1, 750)=6.04 0.014 0.008
Simple reaction time (seconds) (1, 747)= 0.04 0.845 0.000
Four-choice reaction time
(seconds)
(1, 751)= 0.30 0.587 0.000
Inspection time (1, 729)= 11.10 0.001 0.015
General factor: memory
(gmemory)
(1, 739)=5.43 0.020 0.007
Logical memory (1, 753)=6.23 0.013 0.008
Verbal paired associates (1, 741)= 1.03 0.311 0.001
Spatial span (1, 751)=7.10 0.008 0.009
Age in days at the time of testing, gender and age 11 IQ statistically
controlled. Associations significant at Po0.05 are in bold.
Table 2. TOMM40 ‘523’ poly-T repeat length genotype and cognitive ability—adjusted for age 11 IQ
Cognitive test Step 1 Whole sample Step 2 ε3/ε4 genotype subgroup
only
Step 3 ε3/ε3 genotype subgroup
only
(d.f.) F statistics P Partial η2 (d.f.) F statistics P Partial η2 (d.f.) F statistics P Partial η2
General factor: intelligence (g) 5, 753= 1.52 0.182 0.010 (1, 186)= 1.04 0.309 0.006 (2, 418)= 0.92 0.401 0.004
Digit span backwards 5, 762= 0.08 0.995 0.001 (1, 187)= 0.07 0.786 0.000 (2, 426)= 0.74 0.476 0.003
Matrix reasoning 5, 761= 0.73 0.602 0.005 (1, 187)= 1.02 0.314 0.005 (2, 425)= 0.56 0.572 0.003
Block design 5, 760= 1.39 0.228 0.009 (1, 187)= 0.25 0.618 0.001 (2, 424)= 1.31 0.277 0.006
Letter-number sequencing 5, 761= 1.19 0.312 0.008 (1, 187)= 4.51 0.035 0.024 (2, 425)= 1.39 0.250 0.007
General factor: processing speed (gspeed) 5, 723= 0.93 0.463 0.006 (1, 173)= 0.31 0.578 0.002 (2, 407)= 0.30 0.739 0.001
Digit symbol coding 5, 760= 0.93 0.459 0.006 (1, 187)= 0.31 0.578 0.002 (2, 424)= 0.89 0.410 0.004
Symbol search 5, 757= 1.18 0.316 0.008 (1, 186)= 0.00 0.951 0.000 (2, 422)= 0.37 0.692 0.002
Simple reaction time (seconds) 5, 754= 0.55 0.741 0.004 (1, 185)= 0.42 0.518 0.002 (2, 421)= 1.25 0.287 0.006
Four-choice reaction time (seconds) 5, 758= 0.35 0.880 0.002 (1, 186)= 0.84 0.462 0.004 (2, 424)= 0.44 0.646 0.002
Inspection time 5, 736= 2.13 0.060 0.014 (1, 177)= 2.26 0.135 0.013 (2, 414)= 0.20 0.820 0.001
General factor: memory (gmemory) 5, 746= 2.11 0.063 0.014 (1, 183)= 0.17 0.685 0.001 (2, 416)= 0.79 0.457 0.004
Logical memory 5, 760= 2.13 0.060 0.014 (1, 186)= 0.27 0.601 0.001 (2, 425)= 2.33 0.099 0.011
Verbal paired associates 5, 748= 0.95 0.449 0.006 (1, 184)= 0.02 0.891 0.000 (2, 417)= 1.09 0.337 0.005
Spatial span 5, 758=2.31 0.043 0.015 (1, 187)= 3.09 0.081 0.016 (2, 422)= 1.25 0.288 0.006
Age in days at the time of testing, gender and age 11 IQ statistically controlled. Associations significant at Po0.05 are in bold.
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coding (indirect effect =− 0.30, 95% CIs =− 0.79 to − 0.05) and
inspection time (indirect effect =− 0.30, 95% CIs =− 0.76 to − 0.06),
but not matrix reasoning (indirect effect =− 0.06, 95% CIs =− 0.20
to 0.17), symbol search (indirect effect =− 0.08, 95% CIs =− 0.30 to
0.21), gmemory (indirect effect =o − 0.00, 95% CIs =− 0.22 to 0.21)
or spatial span (indirect effect =− 0.04, 95% CIs =− 0.12 to 0.01).
Cases of statistically significant mediation are displayed in
Figure 2. Bootstrapping statistics indicated that right ventral
cingulum FA did not significantly mediate the association
between APOE and inspection time total scores.
DISCUSSION
Overview
This report found significant deleterious effects of APOE ε4 allele
possession on several cognitive tasks, independent of age, gender,
childhood IQ and vascular disease history; namely tests of
nonverbal reasoning (matrix reasoning), visuospatial ability (spatial
span), processing speed (digit symbol coding, symbol search,
inspection time), and memory (logical memory total). We also
found significant nominal effects of APOE genotype on general
factors of intelligence, processing speed and memory, constructed
with PCA, consistent with recent large studies.3,36 The current
Table 3. Intercorrelations between cognitive ageing and white matter tract variables that are each significantly associated with APOE ε genotype
r (P-value) Right ventral cingulum FA Left inferior longitudinal fasciculus FA
General factor: intelligence (g) 0.02 (0.347) 0.20 (o0.001)
Matrix reasoning − 0.01 (0.411) 0.10 (0.008)
General factor: processing speed (gspeed) 0.04 (0.196) 0.17 (o0.001)
Digit symbol coding 0.03 (0.276) 0.18 (o0.001)
Symbol search − 0.03 (0.240) 0.11 (0.004)
Inspection time 0.07 (0.042) 0.14 (o0.001)
General factor: memory (gmemory) 0.01 (0.441) 0.08 (0.024)
Logical memory 0.02 (0.328) 0.05 (0.131)
Spatial span −0.02 (0.334) 0.09 (0.015)
Abbreviation: FA, fractional anisotropy. Pearson semi-partial correlations controlling for age, gender and age 11 IQ. Figures reflect ‘r’ correlations. FA, fractional
anisotropy. Significant correlations in bold reflect a significant correlation (Po0.05) where both variables are also associated with APOE ε4 independent of
vascular disease history (Supplementary Table 3).
Left inferior
longitudinal fasciculus 
fractional anisotropy
0.09*
g
(n = 538)
APOE
4 ‘risk’ allele
Digit Symbol 
Coding
(n = 543)
gspeed
(n = 522)
Inspection Time 
(n = 530)
β = 0.12
P < 0.01
0.10**
-0.11**
(-0.10**)
-0.12***
(-0.11)**
-0.15**
(-0.14)**
0.11**
-0.11**
(-0.10*)
0.10*
Note: This table shows associations between APOE 4 possession and FA of the left inferior
longitudinal fasciculus tract. Figures represent standardised beta associations between variables,
and figures in brackets represent those associations after adjustment for inferior longitudinal 
fasciculus FA. Each association attenuates slightly after this correction, reflecting partial mediation.
*P < 0.05; **P <0.01; ***P < 0.001.
Figure 2. Three-way associations between APOE ε, left inferior longitudinal fasciculus tract integrity and cognitive ability adjusted for
age 11 IQ.
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study did not find significant effects of TOMM40 523 genotype
(that remained significant when we added the covariates of APOE
ε4 or vascular disease history). Formal tests of mediation with
bootstrapping showed that the left inferior longitudinal fasciculus
significantly mediated associations between APOE ε4 and g, digit
symbol coding, gspeed and inspection time total scores. This tract
did not completely mediate these significant associations; the
gene-cognitive associations did not attenuate markedly.
All associations with cognitive ability attenuated to nonsignifi-
cance when corrected for type 1 error with FDR. Cognitive
variables are strongly intercorrelated, as reflected by the general
factors that were constructed with PCA. Although FDR is less
affected by test statistics that are based on intercorrelated
variables when compared with other type 1 error adjustment
procedures such as Bonferroni,31 this can still make correction for
multiple testing overly conservative.37 We interpret all significant
raw gene-cognitive associations cautiously, and emphasize that
they require independent replications. These intercorrelations also
highlight the fact that the genetic associations with cognitive
variables are not independent and may partly reflect a degree of
shared variance between these tasks (as indicated by g).
Interpretation: APOE ε genotype
The demonstration that some significant associations between
APOE and aspects of ‘cognitive ageing’ (cognitive test scores in
older age adjusted for childhood intelligence) are mediated by
white matter tract integrity is novel, possibly reflecting the fact
that relatively few studies have the requisite genetic, imaging and
cognitive data.38 This is important because it helps to elucidate
the neural substrates underpinning the association between APOE
and cognitive ageing.
It is plausible that the left inferior longitudinal fasciculus at least
partly mediates specific APOE-cognitive ageing associations. The
inferior longitudinal fasciculus is an occipito-temporal tract.39
Correlations between white matter integrity and cognitive ability
may reflect a ‘computational bottleneck’ whereby lowered
integrity limits the amount of information that can be transmitted
between brain structures (Westlye et al.,40 pp. 514). This would
theoretically strengthen the FA-cognitive correlation:40 for exam-
ple, Ryan et al.13 reported that associations between FA and
cognitive ability in relatively healthy older adults (N= 126) differed
significantly according to APOE genotype (for example, frontal
lobe FA correlated with an 'Executive function' score at r = 0.46 for
ε4 carriers, vs. r= 0.04 in non-carriers); we indirectly add to this
finding with a relatively large study that includes formal tests of
mediation.33 This theory, overall, provides a reasonable biological
explanation for the mediating role of the inferior longitudinal
fasciculus and performance on specific cognitive tasks. It is also
possible that the integrity of this tract correlates significantly with
the actual mechanistic brain phenotype, which was perhaps not
examined here.38
Interpretation: TOMM40 ‘523’ poly-T repeat genotype
We are aware of three previous independent studies of TOMM40
523 genotype and cognitive ability in older adults.6–8 The current
findings in the LBC1936 sample contrast with previous studies in
showing no significant effects of TOMM40 523 genotype,
independent of APOE or vascular disease history. The relatively
small samples reported by Johnson et al.8 (N= 117) and Hayden
et al.7 (N= 127), and the marginal significance reported by Caselli
et al.6 (P= 0.04) caution that previous significant findings may to
an extent reflect type 1 error.
Limitations and future research
This report examined variables that were statistically significantly
intercorrelated at Po0.05, and where mediation would therefore
be most likely (‘Causal Steps’ approach41). A limitation of this
‘Causal Steps’ approach is that each hypothesis test carries a
possibility of type 1 or type 2 error. Rather, Hayes41 suggests
hypothesis-driven testing of indirect effects, regardless of the
statistical significance of the mediator’s association with the
independent and dependent variables; it is possible that
significant APOE-cognitive ageing associations occur via very
small effects on a large, distributed range of brain phenotypes.
Future studies should consider a large-scale examination of APOE
genotype, different brain imaging phenotypes and cognitive
ageing variables, possibly using a structural equation modelling/
path analytic framework formally to test the network of
associations and for the presence of mediation.
There is evidence that APOE genotype may have a significant
effect on brain white matter throughout the lifecourse, including
early development.42–44 This could imply that ageing effects may
be superimposed on underlying vulnerabilities in the way that
brain white matter develops in APOE ε4 carriers (vs non-carriers).
The current sample does not have empirical brain imaging at
younger ages to address this possibility further.
Although APOE ε4 is an established risk factor for late onset
Alzheimer’s disease and for worse cognitive ageing, this
polymorphism accounts for only a small fraction of phenotypic
variance. Other genetic loci or environmental variables are likely to
have significant interactive or independent roles. The approach
described here will be useful in testing similar genetic/brain
imaging/cognitive associations, however future studies will
require large, well-phenotyped cohorts.
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